Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof
US10457703B2 · kind B2 · utility
8Cited by
4References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2016 |
| Grant date | Oct 29, 2019 |
| Priority date | — |
| Expiry date | Mar 30, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J51/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides compounds represented by Formula I, or pharmaceutically acceptable salts, stereoisomers, solvates, hydrates or combination thereof, The invention also provides pharmaceutical compositions comprising these compounds and methods of using this compounds for treating FXR-mediated or TGR5-mediated diseases or conditions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.